Nippon Shinyaku Co Ltd (NPPNY)
7.09
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Nippon Shinyaku Price to Book Value: 1.253 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.253 |
| April 30, 2024 | 1.253 |
| April 29, 2024 | 1.224 |
| April 26, 2024 | 1.224 |
| April 25, 2024 | 1.224 |
| April 24, 2024 | 1.208 |
| April 23, 2024 | 1.208 |
| April 22, 2024 | 1.208 |
| April 19, 2024 | 1.208 |
| April 18, 2024 | 1.362 |
| April 17, 2024 | 1.362 |
| April 16, 2024 | 1.362 |
| April 15, 2024 | 1.362 |
| April 12, 2024 | 1.362 |
| April 11, 2024 | 1.362 |
| April 10, 2024 | 1.362 |
| April 09, 2024 | 1.362 |
| April 08, 2024 | 1.362 |
| April 05, 2024 | 1.362 |
| April 04, 2024 | 1.362 |
| April 03, 2024 | 1.362 |
| April 02, 2024 | 1.362 |
| April 01, 2024 | 1.362 |
| March 28, 2024 | 1.362 |
| March 27, 2024 | 1.304 |
| Date | Value |
|---|---|
| March 26, 2024 | 1.304 |
| March 25, 2024 | 1.304 |
| March 22, 2024 | 1.304 |
| March 21, 2024 | 1.385 |
| March 20, 2024 | 1.385 |
| March 19, 2024 | 1.385 |
| March 18, 2024 | 1.385 |
| March 15, 2024 | 1.385 |
| March 14, 2024 | 1.392 |
| March 13, 2024 | 1.392 |
| March 12, 2024 | 1.392 |
| March 11, 2024 | 1.392 |
| March 08, 2024 | 1.355 |
| March 07, 2024 | 1.355 |
| March 06, 2024 | 1.355 |
| March 05, 2024 | 1.355 |
| March 04, 2024 | 1.403 |
| March 01, 2024 | 1.403 |
| February 29, 2024 | 1.403 |
| February 28, 2024 | 1.403 |
| February 27, 2024 | 1.403 |
| February 26, 2024 | 1.403 |
| February 23, 2024 | 1.447 |
| February 22, 2024 | 1.447 |
| February 21, 2024 | 1.447 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.208
Minimum
Apr 19 2024
4.734
Maximum
Feb 04 2020
2.972
Average
3.081
Median
Mar 31 2022
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8713 |
| Nxera Pharma Co Ltd | 1.757 |
| PeptiDream Inc | 5.939 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 11.29 |
| PS Ratio | 1.824 |
| Price to Free Cash Flow | 23.45 |
| Price | 7.09 |
| Earnings Yield | 8.86% |
| Market Cap | 1.910B |
| Operating PE Ratio | 8.339 |
| Normalized PE Ratio | 11.29 |